##### Table of Contents

---

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



---

FORM 10-QSB



---

[Mark One]

|x | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended September 30, 2007
|- | -----------------------------------------------------------------------------------------------------------------------------------------



| ̈ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from
 to
|- | ---------------------------------------------------------------------------------------------------------------------------

Commission File Number: 0-25203



---

OmniComm Systems, Inc.

(Exact name
of Small Business Issuer as specified in its Charter)



---



|                       |  |                                   
|---------------------- |  | ----------------------------------
|Delaware               |  | 11-3349762                        
|State of Incorporation |  | IRS Employer Identification Number



|                                                        |  |      
|------------------------------------------------------- |  | -----
|2101 W. Commercial Blvd. Suite 4000, Ft. Lauderdale, FL |  | 33309
|Address of principal executive offices                  |  |      

954.473.1254

Issuers Telephone Number:

N/A

(Former name, former address and former fiscal year, if changed since last report)



---

Check whether the Issuer: (1) Filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act
during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    NO ̈

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ̈No  x

The number of shares outstanding of each of the issuers classes of common equity as of November 5, 2007: 57,620,623 common stock $.001 par
value.

Transitional Small Business Disclosure Format (Check one):    Yes ̈No  x



---



---

##### Table of Contents

TABLE OF CONTENTS TO THE QUARTERLY REPORT ON FORM 10-QSB FOR

THE NINE MONTHS ENDED SEPTEMBER 30, 2007



|                                                                                                                                                            |  |   
|----------------------------------------------------------------------------------------------------------------------------------------------------------- |  | --
|PART I. FINANCIAL INFORMATION                                                                                                                               |  |   
|                                                                                                                                                            | 
|Item 1. Unaudited Consolidated Financial Statements                                                                                                         |  |   
|                                                                                                                                                            | 
|Consolidated Balance Sheets  September 30, 2007 and December 31, 2006                                                                                      |  | 3 
|                                                                                                                                                            | 
|Consolidated Statements of Operations  Nine and Three Months Ended September 30, 2007 and September 30, 2006                                               |  | 4 
|                                                                                                                                                            | 
|Consolidated Statements of Cash Flows  Nine months Ended September 30, 2007 and September 30, 2006                                                         |  | 5 
|                                                                                                                                                            | 
|Notes to Consolidated Unaudited Financial Statements                                                                                                        |  | 7 
|                                                                                                                                                            | 
|Item 2. Managements Discussion and Analysis or Plan of Operation                                                                                           |  | 15
|                                                                                                                                                            | 
|Item 3. Controls and Procedures                                                                                                                             |  | 26
|                                                                                                                                                            | 
|PART II. OTHER INFORMATION                                                                                                                                  |  |   
|                                                                                                                                                            | 
|Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.                                                                                        |  | 27
|                                                                                                                                                            | 
|Item 4. Submission of Matters to a Vote of Security Holders.                                                                                                |  | 27
|                                                                                                                                                            | 
|Item 6. Exhibits                                                                                                                                            |  | 28
|                                                                                                                                                            | 
|SIGNATURES                                                                                                                                                  |  | 29
|                                                                                                                                                            | 
|Exhibit 31.1 Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act OF 2002  CEO Cornelis F. Wit                       |  |   
|                                                                                                                                                            | 
|Exhibit 31.2 Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act OF 2002  CFO Ronald T. Linares                     |  |   
|                                                                                                                                                            | 
|Exhibit 32.1 Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act OF 2002  CEOCornelis F. Wit   |  |   
|                                                                                                                                                            | 
|Exhibit 32.2 Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act OF 2002  CFORonald T. Linares |  |   



2



---

##### Table of Contents

OMNICOMM SYSTEMS, INC.

CONSOLIDATED BALANCE SHEETS



|                                                                                                                                                                                                                    |  |                               |             |   |                  |   |             |  
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |  | ----------------------------- | ----------- | - | ---------------- | - | ----------- | -
|                                                                                                                                                                                                                    |  | September 30,2007 (unaudited) |             |   | December 31,2006 |  
|                                                                                                                                                                                                                    |  |                              
|ASSETS                                                                                                                                                                                                              |  |                               |             |   |                  |   |             |  
|CURRENT ASSETS                                                                                                                                                                                                      |  |                               |             |   |                  |   |             |  
|Cash                                                                                                                                                                                                                |  | $                             | 516,848     |   |                  | $ | 38,254      |  
|Accounts receivable, net of allowance for doubtful accounts of $2,586 and $58,539 in 2007 and 2006, respectively                                                                                                    |  |                               | 784,185     |   |                  |   | 286,708     |  
|Prepaid expenses and other assets                                                                                                                                                                                   |  |                               | 15,256      |   |                  |   | 42,026      |  
|                                                                                                                                                                                                                    |  |                               |             |   |                  |   |             |  
|Total current assets                                                                                                                                                                                                |  |                               | 1,316,289   |   |                  |   | 366,988     |  
|                                                                                                                                                                                                                    |  |                              
|PROPERTY AND EQUIPMENT, net                                                                                                                                                                                         |  |                               | 271,217     |   |                  |   | 199,931     |  
|                                                                                                                                                                                                                    |  |                              
|OTHER ASSETS                                                                                                                                                                                                        |  |                               |             |   |                  |   |             |  
|Intangible assets                                                                                                                                                                                                   |  |                               | 2,446       |   |                  |   | 2,686       |  
|Other assets                                                                                                                                                                                                        |  |                               | -0-         |   |                  |   | 12,937      |  
|                                                                                                                                                                                                                    |  |                               |             |   |                  |   |             |  
|TOTAL ASSETS                                                                                                                                                                                                        |  | $                             | 1,589,952   |   |                  | $ | 582,542     |  
|                                                                                                                                                                                                                    |  |                               |             |   |                  |   |             |  
|                                                                                                                                                                                                                    |  |                              
|LIABILITIES AND SHAREHOLDERS EQUITY (DEFICIT)                                                                                                                                                                      |  |                               |             |   |                  |   |             |  
|CURRENT LIABILITIES                                                                                                                                                                                                 |  |                               |             |   |                  |   |             |  
|Accounts payable and accrued expenses                                                                                                                                                                               |  | $                             | 444,354     |   |                  | $ | 645,375     |  
|Accrued payroll taxes                                                                                                                                                                                               |  |                               | 23,127      |   |                  |   | 74,766      |  
|10% Convertible Notes                                                                                                                                                                                               |  |                               | 87,500      |   |                  |   | 100,000     |  
|Notes payable  current portion                                                                                                                                                                                     |  |                               | -0-         |   |                  |   | 350,000     |  
|Deferred revenue                                                                                                                                                                                                    |  |                               | 2,075,268   |   |                  |   | 1,643,566   |  
|                                                                                                                                                                                                                    |  |                               |             |   |                  |   |             |  
|Total current liabilities                                                                                                                                                                                           |  |                               | 2,630,249   |   |                  |   | 2,813,707   |  
|                                                                                                                                                                                                                    |  |                              
|NOTES PAYABLE, net of current portion                                                                                                                                                                               |  |                               | 111,800     |   |                  |   | 415,000     |  
|NOTES PAYABLE RELATED PARTY, net of current portion                                                                                                                                                                 |  |                               | 185,000     |   |                  |   | 185,000     |  
|                                                                                                                                                                                                                    |  |                               |             |   |                  |   |             |  
|TOTAL LIABILITIES                                                                                                                                                                                                   |  |                               | 2,927,049   |   |                  |   | 3,413,707   |  
|                                                                                                                                                                                                                    |  |                               |             |   |                  |   |             |  
|COMMITMENTS AND CONTINGENCIES (see Note 5)                                                                                                                                                                          |  |                               |             |   |                  |   |             |  
|                                                                                                                                                                                                                    |  |                              
|SHAREHOLDERS EQUITY (DEFICIT)                                                                                                                                                                                      |  |                               |             |   |                  |   |             |  
|Undesignated preferred stock$.001 par value. 4,022,500 shares authorized, no shares issued and outstanding                                                                                                         |  |                               | -0-         |   |                  |   | -0-         |  
|                                                                                                                                                                                                                    |  |                              
|Series B convertible preferred stock,$.001 par value. 230,000 shares authorized, 48,000 and 50,000 issued and outstanding, respectively;
liquidation preference $480,000 and $500,000, respectively                |  |                               | 48          |   |                  |   | 50          |  
|                                                                                                                                                                                                                    |  |                              
|Series C convertible preferred stock,$.001 par value. 747,500 shares authorized, 337,150 and 337,150 issued and outstanding,
respectively; liquidation preference $3,371,500 and $3,371,500, respectively          |  |                               | 337         |   |                  |   | 337         |  
|                                                                                                                                                                                                                    |  |                              
|5% Series A convertible preferred stock$0.001 par value, 5,000,000 shares authorized; 4,215,224 and 4,215,224 issued and outstanding,
respectively; liquidation preference $4,215,224 and $4,215,224, respectively |  |                               | 4,215       |   |                  |   | 4,215       |  
|                                                                                                                                                                                                                    |  |                              
|Common stock  150,000,000 shares authorized, 57,620,623 and 47,972,091 issued and outstanding, after deducting 802,612 and 773,878
shares of treasury stock, at $.001 par value, respectively                      |  |                               | 58,374      |   |                  |   | 48,697      |  
|Additional paid in capital  preferred                                                                                                                                                                              |  |                               | 7,683,504   |   |                  |   | 7,703,502   |  
|Additional paid in capital  common                                                                                                                                                                                 |  |                               | 26,844,378  |   |                  |   | 21,719,097  |  
|Stock subscription receivable                                                                                                                                                                                       |  |                               | (40         | ) |                  |   | (1,250      | )
|Less: Treasury stock, cost method, 802,612 and 773,878 shares, respectively                                                                                                                                         |  |                               | (369,389    | ) |                  |   | (351,861    | )
|Accumulated other comprehensive income                                                                                                                                                                              |  |                               | (28,953     | ) |                  |   | (2,041      | )
|Accumulated deficit                                                                                                                                                                                                 |  |                               | (35,529,571 | ) |                  |   | (31,951,911 | )
|                                                                                                                                                                                                                    |  |                               |             |   |                  |   |             |  
|TOTAL SHAREHOLDERS EQUITY (DEFICIT)                                                                                                                                                                                |  |                               | (1,337,097  | ) |                  |   | (2,831,165  | )
|                                                                                                                                                                                                                    |  |                               |             |   |                  |   |             |  
|TOTAL LIABILITIES AND SHAREHOLDERS EQUITY (DEFICIT)                                                                                                                                                                |  | $                             | 1,589,952   |   |                  | $ | 582,542     |  
|                                                                                                                                                                                                                    |  |                               |             |   |                  |   |             |  

See accompanying summary of accounting policies and notes to financial statements.



3



---

##### Table of Contents

OMNICOMM SYSTEMS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)



|                                                        |  |                                        |            |   |                                          |   |            |      |  |   |            |   |  |   |            |  
|------------------------------------------------------- |  | -------------------------------------- | ---------- | - | ---------------------------------------- | - | ---------- | ---- |  | - | ---------- | - |  | - | ---------- | -
|                                                        |  | For the nine months endedSeptember 30, |            |   | For the three months ended September 30, |  
|                                                        |  | 2007                                   |            |   | 2006                                     |   |            | 2007 |  |   | 2006       |  
|Revenues                                                |  |                                        |            |   |                                          |   |            |      |  |   |            |   |  |   |            |  
|Net sales                                               |  | $                                      | 2,741,631  |   |                                          | $ | 2,011,210  |      |  |   | 842,809    |   |  | $ | 788,947    |  
|                                                        |  |                                        |            |  
|Cost of sales                                           |  |                                        | 770,879    |   |                                          |   | 697,931    |      |  |   | 294,858    |   |  |   | 238,117    |  
|                                                        |  |                                        |            |   |                                          |   |            |      |  |   |            |   |  |   |            |  
|Gross margin                                            |  |                                        | 1,970,752  |   |                                          |   | 1,313,279  |      |  |   | 547,951    |   |  |   | 550,830    |  
|                                                        |  |                                        |            |  
|Operating expenses                                      |  |                                        |            |   |                                          |   |            |      |  |   |            |   |  |   |            |  
|Salaries, benefits and related taxes                    |  |                                        | 4,124,147  |   |                                          |   | 2,307,116  |      |  |   | 1,569,760  |   |  |   | 836,383    |  
|Rent & occupancy expenses                               |  |                                        | 238,402    |   |                                          |   | 132,723    |      |  |   | 86,222     |   |  |   | 52,674     |  
|Consulting                                              |  |                                        | 231,926    |   |                                          |   | 281,602    |      |  |   | 68,232     |   |  |   | 130,977    |  
|Legal and professional fees                             |  |                                        | 208,637    |   |                                          |   | 172,940    |      |  |   | 63,263     |   |  |   | 66,508     |  
|Travel                                                  |  |                                        | 195,800    |   |                                          |   | 149,270    |      |  |   | 84,944     |   |  |   | 52,154     |  
|Telephone and internet                                  |  |                                        | 83,551     |   |                                          |   | 63,745     |      |  |   | 35,192     |   |  |   | 23,125     |  
|Selling, general and administrative                     |  |                                        | 367,272    |   |                                          |   | 245,039    |      |  |   | 124,833    |   |  |   | 105,295    |  
|Depreciation and amortization                           |  |                                        | 67,476     |   |                                          |   | 38,675     |      |  |   | 25,346     |   |  |   | 16,470     |  
|                                                        |  |                                        |            |   |                                          |   |            |      |  |   |            |   |  |   |            |  
|Total operating expenses                                |  |                                        | 5,517,211  |   |                                          |   | 3,391,110  |      |  |   | 2,057,792  |   |  |   | 1,283,586  |  
|                                                        |  |                                        |            |   |                                          |   |            |      |  |   |            |   |  |   |            |  
|Operating income (loss)                                 |  |                                        | (3,546,459 | ) |                                          |   | (2,077,831 | )    |  |   | (1,509,841 | ) |  |   | (732,756   | )
|                                                        |  |                                        |            |  
|Other income (expense)                                  |  |                                        |            |   |                                          |   |            |      |  |   |            |   |  |   |            |  
|Interest expense                                        |  |                                        | (48,838    | ) |                                          |   | (229,296   | )    |  |   | (16,439    | ) |  |   | (77,132    | )
|Interest income                                         |  |                                        | 17,637     |   |                                          |   | -0-        |      |  |   | 4,617      |   |  |   | -0-        |  
|                                                        |  |                                        |            |   |                                          |   |            |      |  |   |            |   |  |   |            |  
|(Loss) before taxes and preferred dividends             |  |                                        | (3,577,660 | ) |                                          |   | (2,307,127 | )    |  |   | (1,521,663 | ) |  |   | (809,888   | )
|                                                        |  |                                        |            |   |                                          |   |            |      |  |   |            |   |  |   |            |  
|Net income (loss)                                       |  |                                        | (3,577,660 | ) |                                          |   | (2,307,127 | )    |  |   | (1,521,663 | ) |  |   | (809,888   | )
|                                                        |  |                                        |            |   |                                          |   |            |      |  |   |            |   |  |   |            |  
|Preferred stock dividends in arrears Series A Preferred |  |                                        | (152,474   | ) |                                          |   | (153,600   | )    |  |   | (50,637    | ) |  |   | (51,763    | )
|Preferred stock dividends in arrears Series B Preferred |  |                                        | (29,480    | ) |                                          |   | (32,581    | )    |  |   | (9,644     | ) |  |   | (10,082    | )
|Preferred stock dividends in arrears Series C Preferred |  |                                        | (200,257   | ) |                                          |   | (201,736   | )    |  |   | (66,506    | ) |  |   | (67,984    | )
|                                                        |  |                                        |            |   |                                          |   |            |      |  |   |            |   |  |   |            |  
|Total preferred stock dividends                         |  |                                        | (382,211   | ) |                                          |   | (387,917   | )    |  |   | (126,787   | ) |  |   | (129,829   | )
|                                                        |  |                                        |            |   |                                          |   |            |      |  |   |            |   |  |   |            |  
|Net income (loss) attributable to common stockholders   |  |                                        | (3,959,871 | ) |                                          | $ | (2,695,044 | )    |  |   | (1,648,450 | ) |  | $ | (939,717   | )
|                                                        |  |                                        |            |   |                                          |   |            |      |  |   |            |   |  |   |            |  
|Net (loss) per share, basic and diluted                 |  | ($                                     | 0.07       | ) |                                          | $ | (0.08      | )    |  | $ | (0.03      | ) |  | $ | (0.02      | )
|                                                        |  |                                        |            |   |                                          |   |            |      |  |   |            |   |  |   |            |  
|Weighted average number of shares outstanding           |  |                                        | 54,582,518 |   |                                          |   | 33,151,747 |      |  |   | 56,439,290 |   |  |   | 38,349,658 |  
|                                                        |  |                                        |            |   |                                          |   |            |      |  |   |            |   |  |   |            |  

See accompanying summary of accounting policies and notes to financial statements



4



---

##### Table of Contents

OMNICOMM SYSTEMS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 AND SEPTEMBER 30, 2006

(unaudited)



|                                                                                           |  |      |            |   |      |   |            |  
|------------------------------------------------------------------------------------------ |  | ---- | ---------- | - | ---- | - | ---------- | -
|                                                                                           |  | 2007 |            |   | 2006 |  
|CASH FLOWS FROM OPERATING ACTIVITIES                                                       |  |      |            |   |      |   |            |  
|Net income (loss)                                                                          |  | $    | (3,577,660 | ) |      | $ | (2,307,127 | )
|Adjustment to reconcile net income to net cash provided by (used in) operating activities: |  |      |            |   |      |   |            |  
|Depreciation and amortization                                                              |  |      | 67,476     |   |      |   | 38,675     |  
|Employee stock option wage expense                                                         |  |      | 651,666    |   |      |   | 163,545    |  
|Common stock issued for accrued interest                                                   |  |      | 76,052     |   |      |   | -0-        |  
|Common stock issued for accrued expenses                                                   |  |      | 37,500     |   |      |   | -0-        |  
|Common stock issued in cashless exercise of stock options                                  |  |      | (6,210     | ) |      |   | -0-        |  
|                                                                                           |  |     
|Change in assets and liabilities:                                                          |  |      |            |   |      |   |            |  
|Accounts receivable                                                                        |  |      | (497,478   | ) |      |   | (18,284    | )
|Prepaid expenses and other assets                                                          |  |      | 26,770     |   |      |   | (22,919    | )
|Other assets                                                                               |  |      | -0-        |   |      |   | (11,292    | )
|Accounts payable and accrued expenses                                                      |  |      | (242,037   | ) |      |   | 337,336    |  
|Deferred revenue                                                                           |  |      | 431,701    |   |      |   | 556,125    |  
|                                                                                           |  |      |            |   |      |   |            |  
|Net cash provided by (used in) operating activities                                        |  |      | (3,032,220 | ) |      |   | (1,263,941 | )
|                                                                                           |  |      |            |   |      |   |            |  
|CASH FLOWS FROM INVESTING ACTIVITIES                                                       |  |      |            |   |      |   |            |  
|Investment in intangible assets                                                            |  |      | -0-        |   |      |   | (3,065     | )
|Sales of property and equipment                                                            |  |      | -0-        |   |      |   | 2,500      |  
|Purchase of property and equipment                                                         |  |      | (138,012   | ) |      |   | (206,265   | )
|                                                                                           |  |      |            |   |      |   |            |  
|Net cash provided by (used in) investing activities                                        |  |      | (138,012   | ) |      |   | (206,830   | )
|                                                                                           |  |      |            |   |      |   |            |  
|CASH FLOWS FROM FINANCING ACTIVITIES                                                       |  |      |            |   |      |   |            |  
|Proceeds from issuance of common stock, net of issuance costs                              |  |      | 3,429,966  |   |      |   | 1,486,845  |  
|Proceeds from stock option exercise                                                        |  |      | 30,917     |   |      |   | 1,500      |  
|Proceeds from stock subscription receivable                                                |  |      | 1,250      |   |      |   | -0-        |  
|Proceeds from notes payable                                                                |  |      | 211,800    |   |      |   | 100,000    |  
|Repayments of notes payable                                                                |  |      | -0-        |   |      |   | (20,300    | )
|                                                                                           |  |      |            |   |      |   |            |  
|Net cash provided by (used in) financing activities                                        |  |      | 3,673,933  |   |      |   | 1,568,045  |  
|                                                                                           |  |      |            |   |      |   |            |  
|                                                                                           |  |     
|Effect of exchange rate change on cash and cash equivalents                                |  |      | (25,107    | ) |      |   | 3,338      |  
|Net increase (decrease) in cash and cash equivalents                                       |  |      | 478,594    |   |      |   | 100,612    |  
|Cash and cash equivalents at beginning of period                                           |  |      | 38,254     |   |      |   | 9,931      |  
|                                                                                           |  |      |            |   |      |   |            |  
|Cash and cash equivalents at end of period                                                 |  | $    | 516,848    |   |      | $ | 110,543    |  
|                                                                                           |  |      |            |   |      |   |            |  



5



---

##### Table of Contents

OMNICOMM SYSTEMS, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2007 AND SEPTEMBER
30, 2006

(unaudited)

(continued)



|                                                                     |  |                                        |         |      |   |        
|-------------------------------------------------------------------- |  | -------------------------------------- | ------- | ---- | - | -------
|                                                                     |  | For the nine monthsended September 30,
|                                                                     |  | 2007                                   |         | 2006
|Supplemental Disclosure of Cash Flow Information:                    |  |                                        |         |      |   |        
|Cash paid during the period for:                                     |  |                                        |         |      |   |        
|                                                                     |  |                                       
|Income tax                                                           |  | $                                      | -0-     |      | $ | -0-    
|                                                                     |  |                                        |         |      |   |        
|Interest                                                             |  | $                                      | 10,400  |      | $ | 10,237 
|                                                                     |  |                                        |         |      |   |        
|Non-cash Transactions                                                |  |                                        |         |      |   |        
|Common stock issued in exchange for Notes Payable                    |  | $                                      | 858,230 |      | $ | -0-    
|Common stock issued for accrued interest                             |  | $                                      | 68,552  |      | $ | -0-    
|Conversion of Series B common stock warrants on a cashless basis     |  | $                                      | -0-     |      | $ | 250,000
|Exercise of Series B Placement Agent Unit Option on a cashless basis |  | $                                      | -0-     |      | $ | 557,013
|Conversion of 10% Convertible Notes Payable into common stock        |  | $                                      | 12,500  |      | $ | -0-    
|Common stock tendered in exercise of incentive stock options         |  | $                                      | 28,734  |      | $ | -0-    
|Conversion of Series B Preferred Stock into common stock             |  | $                                      | 20,000  |      | $ | 150,000
|Common stock issued for accrued expenses                             |  | $                                      | 102,375 |      | $ | -0-    

See accompanying summary of accounting policies and notes to financial statements



6



---

##### Table of Contents

OMNICOMM SYSTEMS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)



|NOTE 1: | ORGANIZATION AND NATURE OF OPERATIONS
|------- | -------------------------------------

OmniComm Systems, Inc. (OmniComm or Company) is a healthcare technology
company that provides Web-based electronic data capture (EDC) solutions and related value-added services to pharmaceutical and biotech companies, CRO (CRO), and other clinical trial sponsors. TrialMaster®, the Companys EDC software application, allows clinical trial sponsors and investigative sites to securely collect, validate, transmit, and analyze clinical trial data.

Our ability to compete within the EDC industry is predicated on our ability to continue enhancing and broadening the scope of solutions offered through
TrialMaster. Our research and development (R & D) efforts are focused on developing new, complementary software solutions, as well as enhancing our existing software solutions through the addition of increased functionality.
During the first nine months of fiscal 2007, we spent approximately $638,000 on R & D activities, the majority of which represented salaries to our developers. During the first nine months of fiscal 2006 we spent approximately $557,000 on R
& D activities, which include costs associated with customization of the TrialMaster software for our clients projects.



|NOTE 2: | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
|------- | ------------------------------------------

BASIS OF PRESENTATION AND PRINCIPLES OF CONSOLIDATION

The Companys accounts include those of all of its wholly
owned subsidiaries and have been prepared in conformity with (i) accounting principles generally accepted in the United States of America; and (ii) the rules and regulations of the United States Securities and Exchange Commission. All
significant intercompany accounts and transactions between the Company and its subsidiaries have been eliminated in consolidation.

UNAUDITED FINANCIAL STATEMENTS

The accompanying unaudited consolidated financial statements of OmniComm Systems,
Inc. and its Subsidiaries (the Company) have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information, pursuant to the rules and regulations of the Securities and
Exchange Commission. Pursuant to such rules and regulations, certain financial information and footnote disclosures normally included in the consolidated financial statements have been condensed or omitted. The results for the periods indicated are
unaudited, but reflect all adjustments (consisting only of normally recurring adjustments) which management considers necessary for a fair presentation of operating results.

The operating results for the nine-month period ended September 30, 2007 are not necessarily indicative of the results that may be expected for the
year ended December 31, 2007. These unaudited consolidated financial statements should be read in conjunction with the consolidated financial statements and footnotes thereto included in the Companys Annual Report on Form 10-KSB for the
year ended December 31, 2006.

ESTIMATES IN FINANCIAL STATEMENTS

The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates
and assumptions that affect the amounts reported in the financial statements and footnotes thereto. Actual results may differ from those estimates.



7



---

##### Table of Contents

OMNICOMM SYSTEMS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)



RECLASSIFICATIONS

Certain reclassifications have been made in the 2006 financial statements to conform to the 2007 presentation. These reclassifications did not have any
effect on net income (loss) or shareholders equity.

SEGMENT INFORMATION

The Company operates in one reportable segment.

CASH AND CASH EQUIVALENTS

Cash equivalents consist of highly liquid, short-term investments with maturities of 90
days or less. The carrying amount reported in the accompanying consolidated balance sheets approximates fair value.

ACCOUNTS
RECEIVABLE

Accounts receivable are judged as to collectibility by management and an allowance for bad debts is established as
necessary. The Company had recorded an allowance for uncollectible accounts receivable of $2,586 and $58,539 as of September 30, 2007 and December 31, 2006, respectively.

CONCENTRATION OF CREDIT RISK

Accounts receivable subject the Company to its highest potential concentration of credit risk. The Company reserves for credit losses. The Company does not require collateral on trade accounts receivables. Our top five customers accounted
for approximately 53% of our revenues during the nine months ended September 30, 2007 and approximately 50% of our revenues during the nine months ended September 30, 2006. Three customers accounted individually for 10% or more of our
revenues during the first nine months of fiscal 2007.

PROPERTY AND EQUIPMENT

Property and equipment are recorded at cost. Additions and betterments are capitalized; maintenance and repairs are expensed as incurred. Depreciation is
calculated using the straight-line method over the assets estimated useful life, which is 5 years for leasehold improvements, equipment and furniture and 3 years for software. Gains or losses on disposal are charged to operations.

DEFERRED REVENUE

Deferred
revenue represents cash advances received in excess of revenue earned on on-going contracts. Payment terms vary with each contract but may include an initial payment at the time the contract is executed, with future payments dependent upon the
completion of certain contract phases or targeted milestones. In the event of contract cancellation, the Company is entitled to payment for all work performed through the point of cancellation. As of September 30, 2007, the Company had
$2,075,627 in deferred revenues relating to contracts for services to be performed over periods ranging from 1 month to 5 years.



8



---

##### Table of Contents

OMNICOMM SYSTEMS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)



REVENUE RECOGNITION POLICY

OmniComms revenue model is transaction-based and can be implemented either as an ASP (application service provider) or licensed for implementation
by a customer such as a pharmaceutical company. Revenues are derived from the set-up of clinical trial engagements; on-going maintenance fees incurred throughout the duration of an engagement; fees for report writing and project change orders. The
clinical trials that are conducted using TrialMaster can last from one month to several years. Most of the fees associated with our product including post-setup customer support in the form of maintenance charges are recognized ratably over the term
of the clinical trial. Cost of sales is primarily comprised of programmer salaries and taxes and is expensed as incurred.

The Company
recognizes sales, for both financial statement and tax purposes in accordance with SEC Staff Accounting Bulletin No. 104 Revenue Recognition, corrected copy and 101 Revenue Recognition in Financial Statements (SAB 101).
SAB 101 and 104 require that revenues be recognized ratably over the life of a contract. The Company will periodically record deferred revenues relating to advance payments in contracts.

ADVERTISING

Advertising costs
are expensed as incurred. Advertising costs were $131,995 and $86,195 for the nine months ended September 30, 2007 and September 30, 2006, respectively. Advertising costs consist primarily of amounts we spend in industry trade
publications, in attending or presenting at industry conferences and in developing our public relations and marketing materials.

RESEARCH AND DEVELOPMENT EXPENSES

Software development costs are included in R & D and are expensed as incurred.
Statement of Financial Accounting Standards No. 86 Accounting for the Costs of Computer Software to be Sold, Leased, or Otherwise Marketed, (SFAS 86), requires the capitalization of certain development costs of software
to be sold once technological feasibility is established, which the Company defines as completion to the point of marketability. The capitalized cost is then amortized on a straight-line basis over the estimated product life. To date, the period
between achieving technological feasibility and the general availability of such software has been short and software development costs qualifying for capitalization have been immaterial. Accordingly, the Company has not capitalized any software
development costs under SFAS 86. R & D expense was approximately $638,000 and $557,000 for the nine months ended September 30, 2007 and September 30, 2006 respectively.

EMPLOYEE EQUITY INCENTIVE PLANS

The Company has an employee equity incentive plan, which is more fully described below. Until December 31, 2005, the Company accounted for its equity incentive plan under the intrinsic value recognition and measurement principles of
Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees and related interpretations. Effective with the quarter ended March 31, 2006, the Company began accounting for employee stock options using
the fair-value method. The exercise price of options granted is equal to the market price of OmniComm Systems common stock (defined as the closing bid price reported on the NASD OTC Bulletin-Board) on the date of grant. The value of the granted
options is estimated using a Binomial option pricing model. Because the estimated value is determined as of the date of grant, the actual value ultimately realized by the employee may be significantly different.



9



---

##### Table of Contents

OMNICOMM SYSTEMS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)



SFAS No. 123R requires the use of option pricing models that were not developed for use in
valuing employee stock options. Binomial option pricing models were developed for use in estimating the fair value of short-lived exchange-traded options that have no vesting restrictions and are fully transferable. The Companys employee stock
options have characteristics significantly different from those of traded options. In addition, option pricing models require the input of highly subjective assumptions, including the options expected life and the price volatility of the
underlying stock, and changes in the subjective input assumptions can materially affect the fair value estimate of employee stock options.

The estimated value of employee stock options granted during the nine months ended September 30, 2007 was $741,760 ($926,045 for the nine months ended September 30, 2006). The value of options granted in 2007 and 2006 was
estimated at the date of grant using the following assumptions:



|                              |  |         |   |  |         |  
|----------------------------- |  | ------- | - |  | ------- | -
|                              |  | 2007    |   |  | 2006    |  
|Risk-free interest rate       |  | 4.67    | % |  | 4.67    | %
|Expected years until exercise |  | 6 Years |   |  | 6 Years |  
|Expected stock volatility     |  | 92.9    | % |  | 99.3    | %
|Dividend yield                |  | 0       | % |  | 0       | %

An analysis of historical information is used to determine the Companys assumptions, to the
extent historical information is relevant based on the terms of the grants being issued in any given period.

Description of Stock
Option Plan

In 1998, the Companys Board of Directors approved the 1998 Stock Incentive Plan of OmniComm Systems, (the
1998 Plan). The 1998 Plan provides for granting Incentive Stock Options, Nonqualified Stock Options, Stock Appreciation Rights, Restricted Stock Awards, Phantom Stock Unit Awards and Performance Share Units. Pursuant to the 1998 Plan,
the Company may grant options to purchase up to 12,500,000 shares of the Companys common stock. The term of each option may not exceed ten years from the date of grant, and options vest in accordance with a vesting schedule established by the
Plan administrator. As of September 30, 2007, substantially all of the companys employees were either participating or expected to participate in the 1998 Plan and approximately 9,013,270 options were outstanding. Options granted under
the 1998 Plan will generally expire seven years from the date of grant for most employees and seven years from the date of grant for officers and directors of the Company.

EARNINGS PER SHARE

The
Financial Accounting Standards Board (FASB) issued Statement of Financial Accounting Standards No. 128, Earnings per Share, (SFAS 128). SFAS 128 replaced the previously reported primary and fully diluted
earnings per share with basic and diluted earnings per share. Unlike primary earnings per share, basic earnings per share excludes any dilutive effects of options, warrants, and convertible securities. The diluted earnings per share calculation is
very similar to the previously utilized fully diluted earnings per share calculation method.



10



---

##### Table of Contents

OMNICOMM SYSTEMS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)



Basic earnings per share were calculated using the weighted average number of shares outstanding of
54,582,518 and 33,151,747 for the nine month periods ended September 30, 2007 and September 30, 2006, respectively. Basic earnings per share were calculated using the weighted average number of shares outstanding of 56,439,290 and
38,349,658 for the three month periods ended September 30, 2007 and September 30, 2006, respectively. There were no differences between basic and diluted earnings per share. Options to purchase 9,013,270 shares of common stock at prices
ranging from $.25 to $2.75 per share were outstanding at September 30, 2007. Warrants to purchase 1,316,756 shares of common stock at prices ranging from $0.25 to $0.50 per share were outstanding at September 30, 2007.

The Company granted a Unit Purchase Option (Agent Option) to the Placement Agent of its Series C Convertible Preferred Stock that provides the
Placement Agent the ability to purchase 24,848 Series C Preferred Shares with 496,950 detachable common stock warrants. The exercise of the Agent Option would result in the issuance of an aggregate of 1,490,850 shares of common stock at an exercise
price of $0.25 per share. The warrants and Agent Options were not included in the computation of diluted earnings per share because they have an anti-dilutive effect on net loss per share.

The Companys convertible debt and convertible preferred stock have an anti-dilutive effect on net loss per share and were not included in the
computation of diluted earnings per share.

INCOME TAXES

The Company accounts for income taxes in accordance with Statement of Financial Accounting Standards No. 109, Accounting for Income
Taxes., (SFAS 109). SFAS 109 has as its basic objective the recognition of current and deferred income tax assets and liabilities based upon all events that have been recognized in the financial statements as measured by the
provisions of the enacted tax laws.

Valuation allowances are established when necessary to reduce deferred tax assets to the estimated
amount to be realized. Income tax expense represents the tax payable for the current period and the change during the period in the deferred tax assets and liabilities.

IMPACT OF NEW ACCOUNTING STANDARDS

In September 2006, the FASB issued SFAS No. 157,
Fair Value Measurements, (SFAS 157) to provide enhanced guidance when using fair value to measure assets and liabilities. SFAS 157 defines fair value, establishes a framework for measuring fair value in generally accepted
accounting principles, and expands disclosures about fair value measurements. The standard applies whenever other standards require or permit assets or liabilities to be measured at fair value and, while not requiring new fair value measurements,
may change current practices. The standard is effective for the Company beginning in fiscal 2009. The Company is currently evaluating the impact SFAS 157 will have on its consolidated financial statements.

In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities  Including an
amendment of FASB Statement No. 115 (SFAS 159). SFAS 159 permits entities to choose to measure certain financial assets and liabilities at fair value at specified election dates. The statement also establishes presentation and
disclosure requirements designed to facilitate comparisons between entities that choose different measurement attributes for similar types of assets and liabilities. The statement is effective for the Company beginning in fiscal 2009. The Company
has not yet determined the impact, if any, of the adoption of SFAS 159.



11



---

##### Table of Contents

OMNICOMM SYSTEMS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)



|NOTE 3: | OPERATIONS AND LIQUIDITY
|------- | ------------------------

We have
experienced negative cash flow from operations and have funded our activities to date primarily from debt and equity financings. We will continue to require substantial funds to continue our R & D activities and to market, sell and commercialize
our technology. We may need to raise substantial additional capital to fund our future operations. Our capital requirements will depend on many factors, including the problems, delays, expenses and complications frequently encountered by companies
developing and commercializing new technologies; the progress of our R & D activities; the rate of technological advances; determinations as to the commercial potential of our technology under development; the status of competitive technology;
the establishment of collaborative relationships; the success of our sales and marketing programs; and other changes in economic, regulatory or competitive conditions in our planned business.

Estimates about the adequacy of funding for our activities are based upon certain assumptions, including assumptions that the R & D programs relating
to our technology can be conducted at projected costs and that progress towards the commercialization of our technology will be timely and successful. There can be no assurance that changes in our R & D plans, acquisitions or other events will
not result in accelerated or unexpected expenditures.

To satisfy our capital requirements, we may seek additional financing through debt
and equity financings. There can be no assurance that any such funding will be available to us on favorable terms or at all. If adequate funds are not available when needed, we may be required to delay, scale back or eliminate some or all of our
research and product development and marketing programs. If we are successful in obtaining additional financings, the terms of such financings may have the effect of diluting or adversely affecting the holdings or the rights of the holders of our
common and preferred stock.

The ability of the Company to continue in existence is dependent on its having sufficient financial resources
to bring products and services to market for marketplace acceptance. As a result of its significant losses, negative cash flows from operations, and accumulated deficits for the period ending September 30, 2007 there is doubt about the
Companys ability to continue as a going concern.



12



---

##### Table of Contents

OMNICOMM SYSTEMS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)



|NOTE 4: | NOTES PAYABLE
|------- | -------------

At September 30, 2007,
the Company owed $296,800 in notes payable. The table below provides details as to the terms and conditions of the notes payable.



|                 |  |          |  |               |   |  |        |         |            |   |           |  |   |        
|---------------- |  | -------- |  | ------------- | - |  | ------ | ------- | ---------- | - | --------- |  | - | -------
|Origination Date |  | Due Date |  | Interest Rate |   |  | Amount |         | Short Term |   | Long Term
|01/16/07         |  | 01/01/09 |  | 9.00          | % |  | $      | 51,800  |            | $ | -0-       |  | $ | 51,800 
|01/16/07         |  | 01/01/09 |  | 9.00          | % |  |        | 60,000  |            |   | -0-       |  |   | 60,000 
|12/31/06         |  | 01/01/09 |  | 9.00          | % |  |        | 185,000 |            |   | -0-       |  |   | 185,000
|                 |  |          |  |               |   |  |        |         |            |   |           |  |   |        
|                 |  |          |  |               |   |  | $      | 296,800 |            | $ | -0-       |  | $ | 296,800
|                 |  |          |  |               |   |  |        |         |            |   |           |  |   |        



|NOTE 5: | COMMITMENTS AND CONTINGENCIES
|------- | -----------------------------

The Company
currently leases office space under an operating lease. The minimum future lease payments required under the Companys operating leases at September 30, 2007 are as follows:



|      |  |   |        
|----- |  | - | -------
|2007  |  | $ | 66,140 
|2008  |  |   | 275,058
|2009  |  |   | 247,833
|2010  |  |   | 253,014
|2011  |  |   | 84,919 
|      |  |   |        
|Total |  | $ | 926,964
|      |  |   |        

In addition to annual base rental payments the Company pays for the operating expenses associated
with its leased office space and is responsible for any escalation in operating expenses as determined in the lease. Rent expense was $238,402 and $132,723 for the nine months ended September 30, 2007 and September 30, 2006, respectively.



|NOTE 6: | RELATED PARTY TRANSACTIONS
|------- | --------------------------

Guus van
Kesteren, a member of our Board of Directors, is a consultant to Noesis Capital Corp. Noesis Capital Corp. has acted as a placement agent for the sale of our securities in various offerings since 1999.

During September 2007, Cornelis Wit, our President and CEO and a member of our Board of Directors, purchased 150,000 share of common stock at a price of
$0.67 per share resulting in gross proceeds to the Company of $100,500.

During March 2007, Fernando Montero, who was appointed as a member
of our Board of Directors on July 27, 2007, purchased 500,000 shares of our common stock at a price of $0.50 per share, resulting in gross proceeds to the Company of $250,000. In addition, Atlantic Balanced Fund, a corporation formed under the
laws of the British Virgin Islands (ABF) purchased 2,500,000 shares of our common stock resulting in gross proceeds to the Company of $1,250,000. Mentor Capital Corporation is the fund manager for ABF and has voting and dispositive
control over the shares held by ABF. Mr. Montero is the president, director and sole owner of Mentor Capital Corporation and may be considered the beneficial owner of the 2,500,000 shares held by ABF.



13



---

##### Table of Contents

OMNICOMM SYSTEMS, INC.

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)



|NOTE 7: | SUBSEQUENT EVENTS
|------- | -----------------

During October 2007, we
sold an aggregate of 623,881 shares of our common stock to accredited investors resulting in gross proceeds of $418,000. This private placement was exempt from registration under the Securities Act of 1933, as amended, in reliance on Rule 506 of
Regulation D. No general solicitation or advertising was used in connection with this transaction, and the certificates evidencing the shares that were issued contained a legend restricting their transferability absent registration under the
Securities Act or the availability of an applicable exemption therefrom. Each purchaser represented that he/she was an accredited investor and was acquiring the shares for investment purposes only, and not with a view towards distribution or resale
except in compliance with applicable securities laws. The investors had full access to, or were otherwise provided with, all relevant information reasonably necessary to evaluate us. None of these investors, except Cornelis Wit, our President and
CEO and a member of our Board of Directors who purchased 150,000 shares, were our affiliates. The Company will record a placement fee of $33,440 payable to the Placement Agent, Noesis Capital, for the Private Placement of these securities.



14



---

##### Table of Contents

ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OR PLAN OF OPERATIONS

General

The following information should be read in conjunction with the Consolidated Audited Financial Statements and Notes thereto and other information set forth in this
report.

Forward-Looking Statements

Statements
contained in this Form 10-QSB that are not historical fact are forward looking statements. These statements can often be identified by the use of forward-looking terminology such as estimate, project,
believe, expect, may, will, should, intends, or anticipates or the negative thereof or other variations thereon or comparable terminology, or by discussions of
strategy that involve risks and uncertainties. We wish to caution the reader that these forward-looking statements, contained in this Form 10-QSB regarding matters that are not historical facts, are only predictions. No assurance can be given that
plans for the future will be consummated or that the future results indicated, whether expressed or implied, will be achieved. While sometimes presented with numerical specificity, these plans and projections and other forward-looking statements are
based upon a variety of assumptions, which we consider reasonable, but which nevertheless may not be realized. Because of the number and range of the assumptions underlying our projections and forward-looking statements, many of which are subject to
significant uncertainties and contingencies that are beyond our reasonable control, some of the assumptions inevitably will not materialize, and unanticipated events and circumstances may occur subsequent to the date of this Form 10-QSB. Therefore,
our actual experience and results achieved during the period covered by any particular projections or forward-looking statements may differ substantially from those projected. Consequently, the inclusion of projections and other forward- looking
statements should not be regarded as a representation by us or any other person that these plans will be consummated or that estimates and projections will be realized, and actual results may vary materially. There can be no assurance that any of
these expectations will be realized or that any of the forward-looking statements contained herein will prove to be accurate. The Company does not undertake any obligation to update or revise any forward-looking statement made by it or on its
behalf, whether as a result of new information, future events or otherwise.

Overview

We are a healthcare technology company that provides electronic data capture (EDC) solutions and related value-added services to pharmaceutical and biotechnology companies, clinical research organizations
(CRO), and other clinical trial sponsors via our Web-based software, TrialMaster. TrialMaster allows clinical trial sponsors and investigative sites to securely collect, validate, transmit, and analyze clinical study data including
patient histories, patient dosing, adverse events, and other clinical trial information. All of our personnel are involved in the development, marketing or support of TrialMaster and its related products.

During fiscal 2007, the Company has sought and will continue to seek to execute its operating strategy. The primary focus of our strategy includes:



| |  |  | Expanding our business model by offering our software solution, TrialMaster, on a licensed basis in addition to our existing hosted-services solutions;
| | - |  | -------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | Expanding our sales and marketing efforts to include larger pharmaceutical, CRO and governmental clinical trial sponsors who will be attracted to our licensed,
technology-transfer business model;
| | - |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| |  |  | Stimulating demand by providing clinical trial Sponsors with high value EDC;
| | - |  | ----------------------------------------------------------------------------



| |  |  | Emphasizing low operating costs;
| | - |  | --------------------------------



| |  |  | Continuing to provide EDC services to small and midsize Pharma, Bio-Tech, Medical Device Companies and CROs; and
| | - |  | ----------------------------------------------------------------------------------------------------------------



| |  |  | Differentiation through service.
| | - |  | --------------------------------

A crucial success
factor in the EDC industry is the overall penetration of our industry into the domestic and international clinical trial market. Health Industry Insights, an industry publication, estimates that as of 2007 approximately 45% of clinical trials are
conducted with the use of EDC. CenterWatch estimates that U.S. clinical R & D was at $31.5 billion in 2005. Based on a 2002 CenterWatch report approximately 8.5% of total R & D costs are spent on data management. Our operating focus is first
to increase our sales and marketing capabilities and penetration rate and secondly, to continue developing and improving TrialMaster to ensure our services and products remain an attractive, high-value EDC choice.



15



---

##### Table of Contents

Our ability to compete within the EDC industry is predicated on our ability to continue enhancing and broadening the
scope of solutions offered through TrialMaster. Our R & D efforts are focused on developing new, complementary software solutions, as well as enhancing our existing software solutions through the addition of increased functionality. During the
first nine months of fiscal 2007 and 2006, we spent approximately $638,000 and $557,000 respectively, on R & D activities, the majority of which represented salaries to our developers which include costs associated with customization of the
TrialMaster software for our clients projects.

The Nine months ended September 30, 2007 Compared with the Nine-months ended
September 30, 2006

Results of Operations

A summarized version of our results of operations for the nine-months ended September 30, 2007 and September 30, 2006 is included in the table below.

Summarized Statement of Operations



|                                               |  |                                         |            |   |              |        |   |      |   |            |              |  |        |          |  |   |            |   |  |       |  
|---------------------------------------------- |  | --------------------------------------- | ---------- | - | ------------ | ------ | - | ---- | - | ---------- | ------------ |  | ------ | -------- |  | - | ---------- | - |  | ----- | -
|                                               |  | For the nine months ended September 30, |            |   |              |        |   |      |  
|                                               |  | 2007                                    |            |   | % ofRevenues |        |   | 2006 |   |            | % ofRevenues |  |        | $ Change |  |   | % Change   |  
|Total revenues                                 |  | $                                       | 2,741,631  |   |              |        |   |      | $ | 2,011,210  |              |  |        |          |  | $ | 730,421    |   |  | 36.3  | %
|Cost of sales                                  |  |                                         | 770,879    |   |              | 28.1   | % |      |   | 697,931    |              |  | 34.7   | %        |  |   | 72,948     |   |  | 10.5  | %
|                                               |  |                                         |            |   |              |        |   |      |   |            |              |  |        |          |  |   |            |   |  |       |  
|Gross margin                                   |  |                                         | 1,970,752  |   |              | 71.9   | % |      |   | 1,313,279  |              |  | 65.3   | %        |  |   | 657,473    |   |  | 50.1  | %
|                                               |  |                                         |            |   |              |       
|Salaries, benefits and related taxes           |  |                                         | 4,124,147  |   |              | 150.4  | % |      |   | 2,307,116  |              |  | 114.7  | %        |  |   | 1,817,031  |   |  | 78.8  | %
|Rent                                           |  |                                         | 238,402    |   |              | 8.7    | % |      |   | 132,723    |              |  | 6.6    | %        |  |   | 105,679    |   |  | 79.6  | %
|Consulting                                     |  |                                         | 231,926    |   |              | 8.5    | % |      |   | 281,602    |              |  | 14.0   | %        |  |   | (49,676    | ) |  | -17.6 | %
|                                               |  |                                         |            |   |              |       
|Selling, general and administrative            |  |                                         | 367,272    |   |              | 13.4   | % |      |   | 245,039    |              |  | 12.2   | %        |  |   | 122,233    |   |  | 49.9  | %
|Total Operating Expenses                       |  |                                         | 5,517,211  |   |              | 201.2  | % |      |   | 3,391,110  |              |  | 168.6  | %        |  |   | 2,126,101  |   |  | 62.7  | %
|                                               |  |                                         |            |   |              |        |   |      |   |            |              |  |        |          |  |   |            |   |  |       |  
|Operating income (loss)                        |  |                                         | (3,546,459 | ) |              | -129.4 | % |      |   | (2,077,831 | )            |  | -103.3 | %        |  |   | (1,468,628 | ) |  | 70.7  | %
|                                               |  |                                         |            |   |              |       
|Interest Expense                               |  |                                         | 48,838     |   |              | 1.8    | % |      |   | 229,296    |              |  | 11.4   | %        |  |   | (180,458   | ) |  | -78.7 | %
|Interest income                                |  |                                         | 17,637     |   |              | 0.6    | % |      |   |           |              |  | 0.0    | %        |  |   | 17,637     |   |  | 0.0   | %
|                                               |  |                                         |            |   |              |        |   |      |   |            |              |  |        |          |  |   |            |   |  |       |  
|Net (loss)                                     |  |                                         | (3,577,660 | ) |              | -130.5 | % |      |   | (2,307,127 | )            |  | -114.7 | %        |  |   | (1,270,533 | ) |  | 55.1  | %
|Total preferred stock dividends                |  |                                         | (382,211   | ) |              | -13.9  | % |      |   | (387,917   | )            |  | -19.3  | %        |  |   | 5,706      |   |  | -1.5  | %
|                                               |  |                                         |            |   |              |        |   |      |   |            |              |  |        |          |  |   |            |   |  |       |  
|Net (loss) attributable to common stockholders |  | $                                       | (3,959,871 | ) |              | -144.4 | % |      | $ | (2,695,044 | )            |  | -134.0 | %        |  | $ | (1,264,827 | ) |  | 46.9  | %
|                                               |  |                                         |            |   |              |        |   |      |   |            |              |  |        |          |  |   |            |   |  |       |  



16



---

##### Table of Contents

Results of Operations

Revenues for the nine-months ended September 30, 2007 were $2,741,631 compared to $2,011,210 for the nine-months ended September 30, 2006, an increase of 36.3%. The revenue increase can be attributed to a 57% increase in projects
under management. Industry acceptance of EDC continues to increase and Health Industry Insights, an industry trade group, estimates that EDC use in 2006 was an estimated 30% of clinical trials. TrialMaster is currently sold primarily as an
application service provider (ASP) that provides EDC and other services such as an enterprise management suite which assists its clients in the pharmaceutical, biotechnology and medical device industries in accelerating the completion of
clinical trials. As we continue developing TrialMaster and our client relationships mature we expect some of our clients to deploy TrialMaster on a licensed, rather than ASP hosted basis. TrialMaster contracts provide for pricing that is based on
both the size and duration of the clinical trial. Size parameters include the number of case report forms used to collect data and the number of sites utilizing TrialMaster. The client will pay a trial setup fee based on the previously mentioned
factors, and then pay an on-going maintenance fee for the duration of the clinical trial that provides software, network and site support during the trial. During the nine-month period ended September 30, 2007 approximately 62.0% of revenues
was generated by trial setup activities, 29.3% was generated from on-going maintenance fees and approximately 8.6% was generated from fees charged for changes to on-going clinical trial engagements. During the nine-month period ended
September 30, 2006 we generated 71.3% of revenues from setup fees, 18.8% from on-going maintenance fees and 10.0% from project change orders. Generally, our contracts will range in duration from one month to several years. Setup fees are
generally earned prior to the inception of a trial, however, the revenues will be recognized in accordance with SEC Staff Accounting Bulletin No. 101 Revenue Recognition and No. 104 Revenue Recognition, corrected
copy which require that the revenues be recognized ratably over the life of the contract. The maintenance fee revenues are earned and recognized monthly. Costs associated with contract revenues are recognized as incurred.

Our top five customers accounted for approximately 53% of our revenues during the nine-month period ended September 30, 2007 and approximately 50% of our revenues
during the nine-month period ended September 30, 2006. Three customers accounted individually for 10% or more of our revenues during the nine-month period ended September 30, 2007. The loss of any of these contracts or these customers in
the future could adversely affect our results of operations.

Cost of goods sold increased to $770,879 for the nine month period ended September 30,
2007 compared to $697,931 for the nine month period ended September 30, 2006, an increase of 10.5%. Cost of goods sold were approximately 28.1% of sales for the nine-month period ended September 30, 2007 compared to 34.7% for the
nine-month period ended September 30, 2006. Cost of goods sold relates primarily to salaries and related benefits associated with the programmers, developers and systems analysts producing clinical trials on behalf of our clients. Salaries
increased during 2007 due to the addition of three additional programmers and a training specialist as part of our trial operations.

We expect to increase
development programming labor costs on an absolute basis as our trial revenues increase. We expect our cost of goods sold to approximate 25% of sales for the remainder of fiscal 2007. We expect to continue to increase follow-on engagements from
existing clients and expect to increase the CRO portion of our client base. In addition, we expect the cost of service for our licensing business model to approximate 25% of revenues when we begin our licensing operations during the fourth quarter
of fiscal 2007 or first quarter of fiscal 2008.

Salaries and related expenses are our biggest expense at 74.8% of total Operating Expenses for the
nine-month period ended September 30, 2007 compared with 68.0% of total Operating Expenses for the nine-month period ended September 30, 2006. Salaries and related expenses totaled $4,124,147 for the nine-month period ended
September 30, 2007 compared to $2,307,116 for the nine-month period ended September 30, 2006, an increase of 78.8%. During the nine-months ended September 30, 2007 and September 30, 2006 we incurred approximately $651,666 and
$163,545, in salary expense, respectively, in connection with our adoption of SFAS No. 123(R), Share-Based Payment, which establishes standards for transactions in which an entity exchanges its equity instruments for goods or services. This
standard requires a public entity to measure the cost of employee services received in



17



---

##### Table of Contents

exchange for an award of equity instruments based on the grant-date fair value of the award. We expect that the adoption of SFAS 123R will continue to have
an impact on our results of operations in the future. We currently employ approximately 50 employees out of our Fort Lauderdale, Florida corporate office, nine out-of-state employees and we have three employees working for our wholly-owned German
subsidiary. We expect to increase personnel within our production, project management and quality analysis functions in concert with anticipated increases in TrialMaster clients during the remainder of fiscal 2007. We anticipate that the
commercialization of our licensed TrialMaster product will require the addition of employees who will provide installation, implementation, training and other consulting services associated with the transfer of our TrialMaster technology on a
licensed basis. We expect that the costs incurred related to the technology transfers of TrialMaster on a licensed basis will be offset by the revenues generated from these sales. We will look to selectively add experienced sales and marketing
personnel in fiscal 2008 in an effort to increase our market penetration and to continue broadening our client base.

Rent and related expenses increased
by $105,679 during the nine-month period ended September 30, 2007 when compared to the nine-month period ended September 30, 2006. This increase was primarily due to the increase in rent under a new corporate office lease entered into in
May 2006 that runs through April 2011. In December 2001, we established a disaster recovery site at an IBM owned Co-Location facility in Atlanta, Georgia and will continue utilizing this facility for the foreseeable future since it is designed to
ensure 100% production system up-time and to provide system redundancy. In August 2006, we entered into a lease with Gold Coast 1-Vault in the Ft. Lauderdale, Florida area. This facility provides us with disaster recovery and business continuity
services for our operations. This lease expires in August 2008.

Legal and professional fees totaled $208,637 for the nine month period ended
September 30, 2007 compared with $172,940 for the nine month period ended September 30, 2006, an increase of approximately $35,697, due primarily to an increase in accounting services provided by our payroll service provider and an
increase in audit and audit related fees. We recorded $67,500 in financial advisory fees during the nine months ended September 30, 2007 compared with $60,000 for the nine months ended September 30, 2006. Professional fees include fees
paid to our auditors for services rendered on a quarterly and annual basis in connection with our SEC filings and fees paid to our attorneys in connection with representation in matters involving litigation or for services rendered to us related to
securities and SEC related matters. We expect legal and professional fees to increase during fiscal 2007 in connection with our project aimed at ensuring timely compliance with Section 404 of the Sarbanes-Oxley Act of 2002.

Selling, general and administrative expenses (SGA) were $367,272 for the nine month period ended September 30, 2007 compared to $245,039 for the nine
month period ended September 30, 2006, an increase of 49.9%. These expenses relate primarily to costs incurred in running our office day-to-day and other costs not directly related to other captioned items in our income statement, and include
the cost of office equipment and supplies, the costs of attending conferences and seminars and other expenses incurred in the normal course of business. The Company increased its marketing, sales and advertising expenditures by $45,800 for the nine
month period ended September 30, 2007 from $86,195 for the nine month period ended September 30, 2006 to $131,995 for the nine month period ended September 30, 2007, an increase of approximately 53.1%. We expect SGA expenses to
continue increasing as we intensify and extend our selling and marketing efforts.

Interest expense was $48,838 during the nine month period ended
September 30, 2007 compared to $229,296 for the nine-month period ended September 30, 2006, a decrease of $180,458 or 78.7%. The decrease can be attributed to the conversion of long-term debt in the aggregate amount of $3,851,042 we
effected in December 2006 and March 2007.

We evaluate the cost of capital available to us in combination with our overall capital structure in deciding
what financing best fulfills our short and long-term capital needs. During the nine-month period ended September 30, 2007 we issued $211,800 in promissory notes. During the nine-month period ended September 30, 2006 we issued $100,000 in
promissory notes.

There were arrearages of $152,474 in 5% Series A Preferred Stock dividends, $29,480 in Series B Preferred Stock dividends and $200,257
in Series C Preferred Stock dividends for the nine month period ended September 30, 2007, compared with arrearages of $153,600 in 5% Series A Preferred Stock dividends, $32,581 in Series B Preferred Stock dividends and $201,736 in Series C
Preferred Stock dividends for the nine month period ended September 30, 2006. We deducted $382,211 and $387,917 to calculate Net Income (Loss) Attributable to Common Stockholders for the nine-month periods ended September 30, 2007 and
September 30, 2006, respectively, relating to undeclared Series A, B and C Convertible Preferred Stock dividends.



18



---

##### Table of Contents

The Three Months ended September 30, 2007 Compared with the Three-Months ended September 30, 2006

Results of Operations

A summarized version of
our results of operations for the three-months ended September 30, 2007 and September 30, 2006 is included in the table below.

Summarized Statement of Operations



|                                               |  |                                          |            |   |              |        |   |      |   |           |              |  |        |          |  |   |          |   |  |       |  
|---------------------------------------------- |  | ---------------------------------------- | ---------- | - | ------------ | ------ | - | ---- | - | --------- | ------------ |  | ------ | -------- |  | - | -------- | - |  | ----- | -
|                                               |  | For the three months ended September 30, |            |   |              |        |   |      |  
|                                               |  | 2007                                     |            |   | % ofRevenues |        |   | 2006 |   |           | % ofRevenues |  |        | $ Change |  |   | % Change |  
|Total revenues                                 |  | $                                        | 842,809    |   |              |        |   |      | $ | 788,947   |              |  |        |          |  | $ | 53,862   |   |  | 6.8   | %
|Cost of sales                                  |  |                                          | 294,858    |   |              | 35.0   | % |      |   | 238,117   |              |  | 30.2   | %        |  |   | 56,741   |   |  | 23.8  | %
|                                               |  |                                          |            |   |              |        |   |      |   |           |              |  |        |          |  |   |          |   |  |       |  
|Gross margin                                   |  |                                          | 547,951    |   |              | 65.0   | % |      |   | 550,830   |              |  | 69.8   | %        |  |   | (2,879   | ) |  | -0.5  | %
|                                               |  |                                          |            |   |              |       
|Salaries, benefits and related taxes           |  |                                          | 1,569,760  |   |              | 186.3  | % |      |   | 836,383   |              |  | 106.0  | %        |  |   | 733,377  |   |  | 87.7  | %
|Travel                                         |  |                                          | 84,944     |   |              | 10.1   | % |      |   | 52,154    |              |  | 6.6    | %        |  |   | 32,790   |   |  | 62.9  | %
|Selling, general and administrative            |  |                                          | 124,833    |   |              | 14.8   | % |      |   | 105,295   |              |  | 13.3   | %        |  |   | 19,538   |   |  | 18.6  | %
|Bad debt expense                               |  |                                          |           |   |              | 0.0    | % |      |   |          |              |  | 0.0    | %        |  |   |         |   |  | N/M   |  
|Depreciation and amortization                  |  |                                          | 25,346     |   |              | 3.0    | % |      |   | 16,470    |              |  | 2.1    | %        |  |   | 8,876    |   |  | 53.9  | %
|                                               |  |                                          |            |   |              |        |   |      |   |           |              |  |        |          |  |   |          |   |  |       |  
|Total Operating Expenses                       |  |                                          | 2,057,792  |   |              | 244.2  | % |      |   | 1,283,586 |              |  | 162.7  | %        |  |   | 774,206  |   |  | 60.3  | %
|                                               |  |                                          |            |   |              |        |   |      |   |           |              |  |        |          |  |   |          |   |  |       |  
|Operating income (loss)                        |  |                                          | (1,509,841 | ) |              | -179.1 | % |      |   | (732,756  | )            |  | -92.9  | %        |  |   | (777,085 | ) |  | 106.0 | %
|                                               |  |                                          |            |   |              |       
|Interest Expense                               |  |                                          | 16,439     |   |              | 2.0    | % |      |   | 77,132    |              |  | 9.8    | %        |  |   | (60,693  | ) |  | -78.7 | %
|Interest income                                |  |                                          | 4,617      |   |              | 0.5    | % |      |   |          |              |  | 0.0    | %        |  |   | 4,617    |   |  | N/M   |  
|                                               |  |                                          |            |   |              |        |   |      |   |           |              |  |        |          |  |   |          |   |  |       |  
|(Loss) before income taxes and dividends       |  |                                          | (1,521,663 | ) |              | -180.5 | % |      |   | (809,888  | )            |  | -102.7 | %        |  |   | (711,775 | ) |  | 87.9  | %
|Income tax expense (benefit)                   |  |                                          | -0-        |   |              | 0.0    | % |      |   | -0-       |              |  | 0.0    | %        |  |   | -0-      |   |  | N/M   |  
|                                               |  |                                          |            |   |              |        |   |      |   |           |              |  |        |          |  |   |          |   |  |       |  
|Net (loss)                                     |  |                                          | (1,521,663 | ) |              | -180.5 | % |      |   | (809,888  | )            |  | -102.7 | %        |  |   | (711,775 | ) |  | 87.9  | %
|                                               |  |                                          |            |   |              |       
|Total preferred stock dividends                |  |                                          | (126,787   | ) |              | -15.0  | % |      |   | (129,829  | )            |  | -16.5  | %        |  |   | 3,042    |   |  | -2.3  | %
|                                               |  |                                          |            |   |              |        |   |      |   |           |              |  |        |          |  |   |          |   |  |       |  
|Net (loss) attributable to common stockholders |  | $                                        | (1,648,450 | ) |              | -195.6 | % |      | $ | (939,717  | )            |  | -119.1 | %        |  | $ | (708,733 | ) |  | 75.4  | %
|                                               |  |                                          |            |   |              |        |   |      |   |           |              |  |        |          |  |   |          |   |  |       |  



19



---

##### Table of Contents

Results of Operations

Revenues for the three-months ended September 30, 2007 were $842,809 compared to $788,947 for the three-months ended September 30, 2006, an increase of 6.8%. The revenue increase can be attributed to a 57% increase in projects
under management. Industry acceptance of EDC continues to increase and Health Industry Insights, an industry trade group, estimates that EDC use in 2006 was an estimated 30% of clinical trials. TrialMaster is currently sold primarily as an
application service provider (ASP) that provides EDC and other services such as an enterprise management suite which assists its clients in the pharmaceutical, biotechnology and medical device industries in accelerating the completion of
clinical trials. As we continue developing TrialMaster and our client relationships mature we expect some of our clients to deploy TrialMaster on a licensed, rather than ASP hosted basis. TrialMaster contracts provide for pricing that is based on
both the size and duration of the clinical trial. Size parameters include the number of case report forms used to collect data and the number of sites utilizing TrialMaster. The client will pay a trial setup fee based on the previously mentioned
factors, and then pay an on-going maintenance fee for the duration of the clinical trial that provides software, network and site support during the trial. During the three-month period ended September 30, 2007 approximately 56.1% of revenues
was generated by trial setup activities, 33.8% was generated from on-going maintenance fees and approximately 10.2% was generated from fees charged for changes to on-going clinical trial engagements. During the three-month period ended
September 30, 2006 we generated 69.5% of revenues from setup fees, 20.3% from on-going maintenance fees and 10.2% from project change orders. Generally, our contracts will range in duration from one month to several years. Setup fees are
generally earned prior to the inception of a trial, however, the revenues will be recognized in accordance with SEC Staff Accounting Bulletin No. 104 Revenue Recognition, correct copy and No. 101 Revenue Recognition
which require that the revenues be recognized ratably over the life of the contract. The maintenance fee revenues are earned and recognized monthly. Costs associated with contract revenues are recognized as incurred.

Cost of goods sold decreased to $294,858 for the three month period ended September 30, 2007 compared to $238,117 for the three month period ended
September 30, 2006, a decrease of 23.8%. Cost of goods sold were approximately 35.0% of sales for the three-month period ended September 30, 2007 compared to 30.2% for the three-month period ended September 30, 2006. Cost of goods
sold relates primarily to salaries and related benefits associated with the programmers, developers and systems analysts producing clinical trials on behalf of our clients. Salaries increased during 2007 due to the addition of four additional
programmers and a training specialist as part of our trial operations.

We expect to increase development programming labor costs on an absolute basis as
our trial revenues increase. We expect our cost of goods sold to approximate 25% of sales during the remainder of fiscal 2007. We expect to continue to increase follow-on engagements from existing clients and expect to increase the CRO portion of
our client base. In addition, we expect the cost of service for our licensing business model to approximate 25% of revenues when we begin our licensing operations during the fourth quarter of fiscal 2007 or first quarter of fiscal 2008.

Salaries and related expenses are our biggest expense at 76.3% of total Operating Expenses for the three month period ended September 30, 2007 compared with
65.2% of total Operating Expenses for the three month period ended September 30, 2006. Salaries and related expenses totaled $1,569,760 for the three month period ended September 30, 2007 compared to $836,383 for the three month period
ended September 30, 2006, an increase of 87.7%. During the three months ended September 30, 2007 and September 30, 2006 we incurred approximately $345,648 and $-0-, in salary expense, respectively, in connection with our adoption of
SFAS No. 123(R), Share-Based Payment, which establishes standards for transactions in which an entity exchanges its equity instruments for goods or services. This standard requires a public entity to measure the cost of employee services
received in exchange for an award of equity instruments based on the grant-date fair value of the award. We expect that the adoption of SFAS 123R will continue to have an impact on our results of operations in the future. We currently employ
approximately 50 employees out of our Fort Lauderdale, Florida corporate office, nine out-of-state employees and we have two employees working for our wholly-owned German subsidiary. We expect to increase personnel within our production, project
management and quality analysis functions in concert with anticipated increases in TrialMaster clients during fiscal 2007. We anticipate that the commercialization of our licensed TrialMaster product will require the addition of employees who will
provide installation, implementation, training and other



20



---

##### Table of Contents

consulting services associated with the transfer of our TrialMaster technology on a licensed basis. We expect that the costs incurred related to the
technology transfers of TrialMaster on a licensed basis will be offset by the revenues generated from these sales. We will look to selectively add experienced sales and marketing personnel in fiscal 2007 in an effort to increase our market
penetration and to continue broadening our client base.

Rent and related expenses increased by $33,548 during the three month period ended
September 30, 2007 when compared to the three-month period ended September 30, 2006. This increase was primarily due to the increase in rent under a new corporate office lease entered into in May 2006 that runs through April 2011. In
December 2001, we established a disaster recovery site at an IBM owned Co-Location facility in Atlanta, Georgia and will continue utilizing this facility for the foreseeable future since it is designed to ensure 100% production system up-time and to
provide system redundancy. In August 2006, we entered into a lease with Gold Coast 1-Vault in the Ft. Lauderdale, Florida area. This facility provides us with disaster recovery and business continuity services for our operations. This lease expires
in August 2011.

Legal and professional fees totaled $63,263 for the three month period ended September 30, 2007 compared with $66,508 for the three
month period ended September 30, 2006, a decrease of approximately $3,245. We recorded $22,500 in financial advisory fees during the three months ended September 30, 2007 compared with $30,000 for the three months ended September 30,
2006. Professional fees include fees paid to our auditors for services rendered on a quarterly and annual basis in connection with our SEC filings and fees paid to our attorneys in connection with representation in matters involving litigation or
for services rendered to us related to securities and SEC related matters. We expect legal and professional fees to increase during fiscal 2007 in connection with our project aimed at ensuring timely compliance with Section 404 of the
Sarbanes-Oxley Act of 2002.

Selling, general and administrative expenses (SGA) were $124,833 for the three month period ended
September 30, 2007 compared to $105,295 for the three month period ended September 30, 2006, an increase of 18.6%. These expenses relate primarily to costs incurred in running our office day-to-day and other costs not directly related to
other captioned items in our income statement, and include the cost of office equipment and supplies, the costs of attending conferences and seminars and other expenses incurred in the normal course of business. The Company decreased its marketing,
sales and advertising expenditures by $2,162 for the three month period ended September 30, 2007 from $40,478 for the three month period ended September 30, 2006 to $38,316 for the three month period ended September 30, 2007, a
decrease of approximately 5.3%. We expect SGA expenses to continue increasing as we intensify and extend our selling and marketing efforts.

Interest
expense was $16,439 during the three month period ended September 30, 2007 compared to $77,132 for the three-month period ended September 30, 2006, a decrease of $60,693 or 78.7%. The decrease can be attributed to the conversion of
long-term debt in the aggregate amount of $3,851,042 we effected in December 2006 and March 2007.

There were arrearages of $50,637 in 5% Series A
Preferred Stock dividends, $9,644 in Series B Preferred Stock dividends and $66,506 in Series C Preferred Stock dividends for the three month period ended September 30, 2007, compared with arrearages of $51,763 in 5% Series A Preferred Stock
dividends, $10,082 in Series B Preferred Stock dividends and $67,984 in Series C Preferred Stock dividends for the three month period ended September 30, 2006. We deducted $126,787 and $129,829 to calculate Net Income (Loss) Attributable to
Common Stockholders for the three-month periods ended September 30, 2007 and September 30, 2006, respectively, relating to undeclared Series A, B and C Convertible Preferred Stock dividends.



21



---

##### Table of Contents

Liquidity and Capital Resources

We have historically experienced negative cash flows and have relied on the proceeds from the sale of debt and equity securities to fund our operations.

The table provided below summarizes key measures of our liquidity and capital resources:

Liquidity and
Capital Resources



|                                                            |  |                                      |   |  |                   |   |  |           |  
|----------------------------------------------------------- |  | ------------------------------------ | - |  | ----------------- | - |  | --------- | -
|                                                            |  | September 30,2007                    |   |  | December 31,2006  |   |  | Change    |  
|Cash                                                        |  | 516,848                              |   |  | 38,254            |   |  | 478,594   |  
|Accounts Receivable, net of allowance for doubtful accounts |  | 784,1865                             |   |  | 286,708           |   |  | 497,478   |  
|Current Assets                                              |  | 1,316,289                            |   |  | 366,988           |   |  | 949,301   |  
|                                                            |  |                                      |  
|Accounts Payable and accrued expenses                       |  | 444,354                              |   |  | 645,375           |   |  | (201,021  | )
|Accrued payroll taxes                                       |  | 23,127                               |   |  | 74,766            |   |  | (51,639   | )
|Deferred revenue                                            |  | 2,075,268                            |   |  | 1,643,566         |   |  | 431,701   |  
|Convertible notes payable                                   |  | 87,500                               |   |  | 100,000           |   |  | (12,500   | )
|Current Liabilities                                         |  | 2,630,249                            |   |  | 2,813,707         |   |  | (183,459  | )
|                                                            |  |                                      |  
|Working Capital (Deficit)                                   |  | (1,313,960                           | ) |  | (2,446,719        | ) |  | 1,135,666 |  
|                                                            |  |                                     
|                                                            |  | Disclosure for the nine months ended |   |  |                   |  
|                                                            |  | September 30,2007                    |   |  | September 30,2006 |   |  |           |  
|Net cash provided by (used in) operating activities         |  | (3,032,220                           | ) |  | (1,263,941        | ) |  |           |  
|                                                            |  |                                      |  
|Net cash provided by (used in) investing activities         |  | (138,012                             | ) |  | (206,830          | ) |  |           |  
|                                                            |  |                                      |  
|Net cash provided by financing activities                   |  | 3,673,933                            |   |  | 1,568,045         |   |  |           |  
|                                                            |  |                                      |  
|Net increase (decrease) in cash and cash equivalents        |  | 478,594                              |   |  | 100,612           |   |  |           |  

Cash and cash equivalents increased by $478,594 from $38,254 at December 31, 2006 to $516,848 at
September 30, 2007. This was the result of cash provided by financing activities of $3,673,933 offset by cash used in operating activities of approximately $3,032,220 and $138,012 used in investing activities. The significant components of the
activity include a loss from operations of approximately $3,577,660 offset by non-cash transactions of $826,484 and approximately $3,673,933 we raised through the issuance of debt and equity securities offset by $138,012 used in investing activities
and decreases in cash of $281,044 from changes in working capital accounts.



22



---

##### Table of Contents

We are not currently bound by any long or short-term agreements for the purchase or lease of capital expenditures. Any
amounts expended for capital expenditures would be the result of an increase in the capacity needed to adequately service any increase in our business. To date we have paid for any needed additions to our capital equipment infrastructure from
working capital funds and anticipate this being the case in the future. Presently, we have approximately $75,000 planned for capital expenditures to further the Companys growth through the end of 2007, which will be funded through cash from
operations.

Contractual Obligations

The following
table sets forth our contractual obligations as of September 30, 2007:



|                             |  |                        |  |                 |     |  |          |     |  |          |  |         
|---------------------------- |  | ---------------------- |  | --------------- | --- |  | -------- | --- |  | -------- |  | --------
|Contractual Obligations      |  | Payments Due by Period
|                             |  | Total                  |  | Less than1 year |     |  | 1-2Years |     |  | 2-3Years |  | 3-5Years
|Long Term Debt (1)           |  | 384,300                |  | 87,500          | (2) |  | 296,800  | (3) |  | 0        |  | 0       
|Operating Lease Obligations  |  | 926,985                |  | 272,043         |     |  | 254,627  |     |  | 251,706  |  | 148,609 
|Financial Advisory Agreement |  | 202,500                |  | 90,000          |     |  | 90,000   |     |  | 22500    |  | 0       
|                             |  |                        |  |                 |     |  |          |     |  |          |  |         
|Total                        |  | 1,513,785              |  | 449,543         |     |  | 641,427  |     |  | 274,206  |  | 148,609 
|                             |  |                        |  |                 |     |  |          |     |  |          |  |         

---

|1. | Amounts do not include interest to be paid.
|-- | -------------------------------------------

|2. | Includes $87,500 of convertible notes currently in default and due that are convertible into shares of common stock at the option of the debenture holder at a conversion rate of
$1.25 per share.
|-- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|3. | Includes $296,800 in promissory notes bearing interest at 9% annually that mature on January 1, 2009.
|-- | -----------------------------------------------------------------------------------------------------

We have no off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial
condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors.

We are
currently in arrears on principal and interest payments owed totaling $150,022 on our 10% Convertible Notes. We were in default effective January 30, 2002.

We have been operating with a negative cash burn rate since beginning our EDC operations. In order to manage cash flows, we have issued preferred stock, common stock, and debt to satisfy operating expenses and obligations. From January 2006
to December 2006, an aggregate of 7,240,000 common stock warrants originally issued in connection with private placements of our Series B and Series C Preferred stock were exercised. The gross proceeds of the warrant exercises were $1,822,500 and we
incurred no transaction fees in connection with the warrant exercise transactions. From January 2007 to March 2007, an aggregate of 1,360,000 common stock warrants originally issued in connection with private placements of our common stock and
Series C Preferred stock were exercised. The gross proceeds of the warrant exercises were $327,500 and we incurred no transaction fees in connection with the warrant exercise transactions. From February 2007 to March 2007, an aggregate of 5,000,000
shares of common stock were sold in connection with a private placement of our common stock. The gross proceeds of the private placement were $2,500,000 and we incurred no transaction fees in connection with the private placement. During September
2007 an aggregate of 1,014,799 shares of common stock were sold in connection with a private placement of our stock. The gross proceed of the private placement were $679,915 which included $102,375 in accrued expenses that were converted into common
stock as part of the private placement. We incurred $46,203 in transaction fees in connection with the private placement.



23



---

##### Table of Contents

Our selling efforts include marketing our products to several Fortune 1000 pharmaceutical and medical device
manufacturers and several of the largest CROs. We began providing services to some of these entities during 2003 and we have experienced success in broadening our client roster over the past three fiscal years. Continued success in broadening our
existing client relationships and forging new relationships should provide us the opportunity to limit our need for funding our operations via debt and equity capital. Continuing to obtain contracts with clients of this size and reputation should
also increase the credibility of the Company to the clinical trial market.

We experienced increased success in marketing TrialMaster during fiscal 2006
and the first nine months of fiscal 2007. During the last seven fiscal quarters we have entered into approximately $12.1 million in contracts for trials to be serviced over the next five years. These contracts included 53 clinical trial engagements
with twenty seven new clients. These contracts may however, be terminated by our clients at any time. Our focus continues to include increasing our penetration of all phases of the clinical trial market with a continued emphasis on becoming the
market leader in Phase I EDC services. We believe this market is an operating and strategic strength of the Company due to the inherent flexibility that our Phase I TrialMaster product provides us. We believe we have the ability to produce trials
more quickly and economically than our competitors for this specialized and large market. During fiscal 2007, we began commercializing our products on a licensed basis. Our clients will be able to partially or completely license TrialMaster. This
business model provides our clients a more cost efficient means of deploying our EDC solutions on a large-scale basis. Our licensed products, falling under the auspices of either a Technology Transition (partial transfer with some services performed
by OmniComm) or Technology Transfer, should allow us to broaden our potential client base, provides us with a high-margin revenue source and affords us the ability to improve our competitive position within the EDC industry. Additionally, we
continue to focus on adding CROs as strategic and marketing partners. According to Contract Pharma there is an industry-wide emphasis in establishing strategic relationships with CROs. We believe these relationships will provide marketing leverage
in the form of joint marketing and sales efforts and provide an installed base of trained TrialMaster users. This installed base of users should increase our ability to provide rapidly developed, cost effective solutions for our clients.

We believe that the momentum established from new client acquisitions and our ability to retain clients for repeat engagements provide a good operating base from
which to build during 2007. We expect to continue increasing the level of resources deployed in our sales and marketing efforts. We believe that a combination of our lean operating environment and increased success in new client acquisition, coupled
with our ability to retain our existing clients will allow us to compete effectively within the EDC market.

Because of the losses experienced since we
began the commercialization of our TrialMaster application we have needed to continue utilizing the proceeds from the sale of debt and equity securities to fund our working capital needs. When available, capital has been expensive relative to the
valuations that were afforded during the expansion of the Internet sector in 1999 and 2000. The softness in the capital markets earlier this decade coupled with the losses experienced have caused working capital shortfalls. We have used a
combination of equity financing and short-term bridge loans to fund our working capital needs. Other than our current capital and capital we may raise from future debt or equity offerings or short-term bridge loans, we do not have any additional
sources of working capital.

We may continue to require substantial funds to continue our R & D activities and to market, sell and commercialize our
technology. We may need to raise substantial additional capital to fund our future operations. Our capital requirements will depend on many factors, including the problems, delays, expenses and complications frequently encountered by companies
developing and commercializing new technologies; the progress of our R & D activities; the rate of technological advances; determinations as to the commercial potential of our technology under development; the status of competitive technology;
the establishment of collaborative relationships; the success of our sales and marketing programs; the cost of filing, prosecuting, defending and enforcing intellectual property rights; and other changes in economic, regulatory or competitive
conditions in our planned business. Estimates about the adequacy of funding for our activities are based upon certain assumptions, including assumptions that the R & D programs relating to our technology can be conducted at projected costs and
that progress towards broader commercialization of our technology will be timely and successful. There can be no assurance that changes in our R & D plans or other events will not result in accelerated or unexpected expenditures.



24



---

##### Table of Contents

To satisfy our capital requirements, including ongoing future operations, we may seek to raise additional financing
through debt and equity financings. There can be no assurance that any such funding will be available to us on favorable terms or at all. If adequate funds are not available when needed, we may be required to delay, scale back or eliminate some or
all of our research and product development programs, and our business operations. If we are successful in obtaining additional financings, the terms of such financings may have the effect of diluting or adversely affecting the holdings or the
rights of the holders of our common and preferred stock. Further, there can be no assurance that even if such additional capital is obtained or the planned cost reductions are implemented, that we will achieve positive cash flow or profitability or
be able to continue as a business.

Our ability to continue in existence is dependent on our having sufficient financial resources to bring products and
services to market. As a result of our significant losses, negative cash flows from operations, and accumulated deficits for the nine months ending September 30, 2007, there is doubt about our ability to continue as a going concern. In
addition, our auditors Greenberg and Company, LLC, included language which qualified their opinion regarding our ability to continue as a going concern in their report dated February 10, 2007.

CRITICAL ACCOUNTING POLICIES

The preparation of financial statements
and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make judgments, assumptions and estimates that affect the amounts reported. Note 2 of Notes to the Consolidated Financial
Statements describes the significant accounting policies used in the preparation of the consolidated financial statements. Certain of these significant accounting policies are considered to be critical accounting policies, as defined below.

A critical accounting policy is defined as one that is both material to the presentation of our financial statements and requires management to make
difficult, subjective or complex judgments that could have a material effect on our financial condition and results of operations. Specifically, critical accounting estimates have the following attributes: 1) we are required to make assumptions
about matters that are highly uncertain at the time of the estimate; and 2) different estimates we could reasonably have used, or changes in the estimate that are reasonably likely to occur, would have a material effect on our financial condition or
results of operations.

Estimates and assumptions about future events and their effects cannot be determined with certainty. We base our estimates on
historical experience and on various other assumptions believed to be applicable and reasonable under the circumstances. These estimates may change as new events occur, as additional information is obtained and as our operating environment changes.
These changes have historically been minor and have been included in the consolidated financial statements as soon as they became known. In addition, our Management is periodically faced with uncertainties, the outcomes of which are not within our
control and will not be known for prolonged periods of time. Based on a critical assessment of its accounting policies and the underlying judgments and uncertainties affecting the application of those policies, our Management believes that our
consolidated financial statements are fairly stated in accordance with accounting principles generally accepted in the United States (GAAP), and present a meaningful presentation of our financial condition and results of operations.

Our Management believes that the following are our critical accounting policies:

Deferred Revenue

Deferred revenue represents cash advances received in excess of revenue earned on on-going contracts. Payment terms vary
with each contract but may include an initial payment at the time the contract is executed, with future payments dependent upon the completion of certain contract phases or targeted milestones. In the event of contract cancellation, we are entitled
to payment for all work performed through the point of cancellation.

Revenue Recognition Policy

OmniComms revenue model is transaction-based and can be implemented either as an ASP or licensed for implementation by a customer such as a pharmaceutical company.
Revenues are derived from the set-up of clinical trial engagements; on-going



25



---

##### Table of Contents

maintenance fees incurred throughout the duration of an engagement; fees for report writing and change orders. The clinical trials that are conducted using
TrialMaster can last from one month to several years. Most of the fees associated with our product including post-setup customer support in the form of maintenance charges are recognized ratably over the term of the clinical trial. Cost of sales is
primarily comprised of programmer salaries and payroll taxes and is expensed as incurred.

The Company recognizes sales, for both financial statement and
tax purposes, in accordance with SEC Staff Accounting Bulletin No. 104 Revenue Recognition, corrected copy and No. 101 Revenue Recognition in Financial Statements (SAB 101). SAB 101 and 104 require that
revenues be recognized ratably over the life of a contract. In accordance with SAB 101 the Company will record revenues over the estimated lives of the contracts.

Stock Based Compensation.

Options granted to employees under our Stock Option Plan were accounted for by using the intrinsic value method
under APB Opinion No. 25, Accounting for Stock Issued to Employees (APB 25) until December 31, 2005. In October 1995, the Financial Accounting Standards Board (FASB) issued Statement No.123, Accounting for Stock-Based
Compensation (SFAS No. 123), which defines a fair value based method of accounting for stock options. All stock based compensation issued to individuals, other than employees and directors such compensation which is accounted for in
accordance with APB Opinion No. 25, are accounted for in accordance with SFAS No. 123, as amended by SFAS No.148. Effective with the quarter ended March 31, 2006, the Company stopped using the intrinsic value method to value employee
stock options. The Company began accounting for employee stock options using the fair value method effective January 1, 2006.

EFFECT OF
RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

In September 2006, the FASB issued Statement No. 157, Fair Value Measurements
(SFAS 157). SFAS 157 defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles, and expands disclosures about fair value measurements. Subsequently, in February 2007,
the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities (SFAS 159). SFAS 159 permits entities to choose to measure many financial assets and financial liabilities at fair value.
Unrealized gains and losses on items for which the fair value option has been elected are reported in earnings. We expect to adopt both SFAS 157 and SFAS 159 as of January 1, 2008. We are currently assessing the impact of the adoption of these
statements.



|ITEM 3. | CONTROLS AND PROCEDURES
|------- | -----------------------

Based on their evaluation as of the end of
the period covered by this Quarterly Report on Form 10-QSB, being September 30, 2007, the Companys principal executive officer and principal financial officer have concluded that the Companys disclosure controls and procedures as
defined in Rules 13a-14(c) and 15d-14(c) under the Securities Exchange Act of 1934 (the Exchange Act) are effective to ensure (i) that information required to be disclosed by the Company in reports that it files or submits under the
Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (ii) that information required to be disclosed in the reports that we file or submit under
the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure.

There were no significant changes in the Companys internal controls over financial reporting or in other factors that could significantly affect these controls
subsequent to the date of their evaluation and up to the filing date of this Quarterly Report on Form 10-QSB. There were no significant deficiencies or material weaknesses, and therefore there were no corrective actions taken.

It should be noted that any system of controls, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the
system are met. In addition, the design of any control system is based in part upon certain assumptions about the likelihood of future events. Because of these and other inherent limitations of control systems, there can be no assurance that any
design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.



26



---

##### Table of Contents

PART II OTHER INFORMATION



|ITEM 2. | UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
|------- | ------------------------------------------------------------

From
September 2007 through October 2007, we sold an aggregate of 1,638,679 shares of our common stock to accredited investors resulting in gross proceeds of $1,097,915, including $102,375 in accrued expenses owed to Noesis Capital the placement agent of
this private placement into shares of common stock as part of this private placement. This private placement was exempt from registration under the Securities Act of 1933, as amended, in reliance on Rule 506 of Regulation D. No general solicitation
or advertising was used in connection with this transaction, and the certificates evidencing the shares that were issued contained a legend restricting their transferability absent registration under the Securities Act or the availability of an
applicable exemption therefrom. Each purchaser represented that he/she was an accredited investor and was acquiring the shares for investment purposes only, and not with a view towards distribution or resale except in compliance with applicable
securities laws. The investors had full access to, or were otherwise provided with, all relevant information reasonably necessary to evaluate us. None of these investors, except Cornelis Wit, our President and CEO and a member of our Board of
Directors who purchased 150,000 shares, were our affiliates. Noesis Capital Corp., an NASD member firm, acted as placement agent in the offering and as compensation therefore received a commission equal to 8% of the sales made by it or $79,643 and a
warrant to purchase at $0.67 per share, approximately 5% of the shares sold, or 66,794 shares of our common stock.



|ITEM 4. | SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.
|------- | ----------------------------------------------------

We held our
annual stockholders meeting in Fort Lauderdale, Florida on May 18, 2007. Stockholders voted:



| | 1. | To elect four directors to the board of directors to serve until the date of our next annual meeting until their successors have been elected and qualified;
| | -- | ------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2. | To ratify the appointment of Greenberg & Co, as our independent auditors; and
| | -- | -----------------------------------------------------------------------------

With a majority (54%) of the outstanding shares voting either by proxy or in person, the stockholders approved the proposals, voting as follows:



|                       |  |            |  |         |  |        
|---------------------- |  | ---------- |  | ------- |  | -------
|Proposal 1.            |  | For        |  | Against |  | Abstain
|Election of directors: |  |            |  |         |  |        
|Randall G. Smith       |  | 40,408,975 |  | 53,280  |  | -0-    
|Cornelis F. Wit        |  | 40,410,975 |  | 51,280  |  | -0-    
|Guus van Kesteren      |  | 40,411,595 |  | 50,660  |  | -0-    
|Matthew D. Veatch      |  | 40,411,595 |  | 50,660  |  | -0-    



|                                                                          |  |            |  |         |  |        
|------------------------------------------------------------------------- |  | ---------- |  | ------- |  | -------
|Proposal 2.                                                               |  | For        |  | Against |  | Abstain
|To ratify the appointment of Greenberg & Co., as our independent auditors |  | 40,457,095 |  | -0-     |  | 5,160  



27



---

##### Table of Contents

|ITEM 6. | EXHIBITS
|------- | --------

The following documents are filed as a part of this
report or are incorporated by reference to previous filings, if so indicated:



|            |  |                                                                                                                                                                           
|----------- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|EXHIBIT NO. |  | DESCRIPTION                                                                                                                                                               
|31.1        |  | Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, promulgated under the Securities and Exchange Act of 1934, as amended.
|            | 
|31.2        |  | Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, promulgated under the Securities and Exchange Act of 1934, as amended.
|            | 
|32.1        |  | Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes Oxley Act of 2002.                        
|            | 
|32.2        |  | Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes Oxley Act of 2002.                        



28



---

##### Table of Contents

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be
signed on its behalf by the undersigned, thereunto duly authorized.



|                       |  |                                                                                     
|---------------------- |  | ------------------------------------------------------------------------------------
|OmniComm Systems, Inc.
|                       | 
|By:                    |  | /s/ Cornelis F. Wit                                                                 
|                       |  | Cornelis F. Wit, Director, Chief Executive Officer and
President                    
|Date:                  |  | November 14, 2007                                                                   
|                       | 
|By:                    |  | /s/ Ronald T. Linares                                                               
|                       |  | Ronald T. Linares, Vice President of Finance, Chief
Financial and Accounting Officer
|Date:                  |  | November 14, 2007                                                                   



29